Select a second ETF to benchmark against First Trust NYSE Arca Biotechnology ETF (FBT). Compare key metrics including year-to-date performance, management fees, sector exposures and underlying assets to ensure you are selecting the best fund for your investment objectives.
NAV Performance and Flows
Key Data
Compare
FBT
| AuM | $7.75 M | |
| Management Fees | 0.15% | |
| Exp. ratio | 0.71% | |
| Tracking Difference | - |
Historical performance and flows
As of September 22, 2026
| 1M | 3M | YTD | 1Y | 3Y | ||
|---|---|---|---|---|---|---|
| Perf. | FBT | +3.37% | +18.27% | +35.66% | +54.10% | +95.86% |
| Flows | FBT | +$0 M | +$2 M | +$4 M | +$4 M | +$4 M |
Exposure
Countries
FBT
USA
82.19%
Other
17.81%
Sectors
FBT
Healthcare
99.86%
As of September 22, 2026
Top 10 Holdings
FBT
Halozyme Therapeutics, Inc.
4.31%
Corcept Therapeutics, Inc.
4.08%
Repligen Corp.
3.87%
Regeneron Pharmaceuticals, Inc.
3.85%
BeOne Medicines Ltd.
3.83%
BioNTech SE
3.75%
Natera, Inc.
3.73%
Amgen, Inc.
3.70%
argenx SE
3.66%
NeoGenomics, Inc.
3.63%
Diversification
FBT
Total weight of top 10 holdings out of 30 total
38.41%
Characteristics
Compare
FBT
| Provider | First Trust | |
| Management | Passively managed | |
| Benchmark | NYSE Arca Biotechnology Total Return Index - USD | |
| Replication Method | ||
| Asset Class | Equity | |
| Dividend Policy | Distributing | |
| Trailing 12m distribution yield | 0.00% | |
| Meets ESG criteria | No | |
| Inception Date | October 30, 2014 |
Recent articles about FBT
The ETF Market Canada is brought to you by Cboe in partnership with Trackinsight SA who is providing all the data, analysis and editorial content on this site. Unless explicitly stated as such, any information that you receive is not real-time.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.